Despite a significant decline in deaths in children younger than 5 years globally in the past
three decades, preventable and treatable infectious diseases remain the leading cause of …

Background Reducing the burden of death due to infection is an urgent global public health
priority. Previous studies have estimated the number of deaths associated with drug …

Background Neonatal sepsis, particularly gram-negative (GN) bacteria-induced, is a
significant cause of morbidity and mortality in newborns. Healthcare professionals find this …

Background There is limited data on antibiotic treatment in hospitalized neonates in low-and
middle-income countries (LMICs). We aimed to describe patterns of antibiotic use …

The synergistic effect of antibacterial and anti-inflammatory is needed to overcome the
problem of wound healing difficulties. Based on the favorable antibacterial and anti …

Background Despite significant global progress in reducing neonatal mortality, bacterial
sepsis remains a major cause of neonatal deaths. Klebsiella pneumoniae (K. pneumoniae) …

Background Klebsiella pneumoniae is the most common pathogen causing neonatal
infections, leading to high mortality worldwide. Along with increasing antimicrobial use in …

Background Escherichia coli is one of the most common pathogens causing neonatal
infections. Recently, the incidence and drug resistance of E. coli have increased, posing a …

Neonatal sepsis remains one of the key challenges of neonatal medicine, and together with
preterm birth, causes almost 50% of all deaths globally for children younger than 5 years …

Bloodstream infections (BSI) caused by antimicrobial-resistant (AMR) Gram-negative
bacteria (GNB) are a significant cause of morbidity and mortality. Third-generation …